IL6 and rheumatoid arthritis: In addition, through a clinical trial, Briot et al. found that two commonly used RA treatment drugs anakinra (IL-1 receptor antagonist) and tocilizumab (anti-IL-6 monoclonal antibody) might also depend on the Wnt pathway to function [81].